Evaluating Electroacupuncture for Women with Overactive Bladder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the efficacy of electroacupuncture as an adjuvant therapy for women suffering from overactive bladder (OAB), a condition characterized by frequent urination and urgency. The approach combines traditional Chinese medicine principles with conventional Western treatments to assess improvements in urinary symptoms, quality of life, and autonomic nervous system function. Participants will receive either electroacupuncture or sham acupuncture to determine the treatment's effectiveness. The study aims to provide a less invasive alternative to traditional pharmacological treatments, which often have undesirable side effects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female patient aged 20-80 with overactive bladder.

Exclusion Criteria:

* Patient has history of cancer, stroke, or hyperthyroidism..
* Patient isn't willing to accept acupuncture or moxibustion treatment.
* Patient who is pregnant or plan to pregnant.
* Patient with urinary tract infection.
* Patient who had injection of botulinum toxin (Botox®), PTNS or SMN treatment before.
* Patient recieved acupuncture treatment before.

Where it's running

• Buddhist Taipei Tzu Chi General Hospital
  New Taipei City, Taiwan Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Flyte device to help urinary incontinence after pelvic radiation for endometrial or cervical cancer

  This study tests whether a home-use Flyte device, used during guided pelvic floor exercises, can improve urinary incontinence in women who had pelvic radiation for endometrial or cervical cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07662824

• Self-Start Macrobid for post-Botox lower urinary symptoms

  This study tests whether giving a standing prescription for Macrobid after Botox treatment reduces urgent calls, messages, and visits for urinary symptoms compared with usual triage care.

  Recruiting Early Phase 1 The Cleveland Clinic · Cleveland, Ohio · NCT07648290

• ZIDA Control Sock added to medication for overactive bladder with leakage

  This trial will try using the ZIDA Control Sock once a week at home for 12 weeks to see if adding it to your current medication reduces urgency urinary incontinence.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07432659

• Vaginal radiofrequency treatment targeting bladder nerves for overactive bladder in women

  This trial will test whether a single vaginal radiofrequency treatment with the MORPHEUSV device can reduce urgency-related urine leaks in adult women with overactive bladder.

  Recruiting at 5 sites InMode MD Ltd. · Palo Alto, California and 8 other locations · NCT07209397

• Tensi+ European registry for overactive bladder

  This registry will collect information on adults with overactive bladder who use the Tensi+ posterior tibial nerve stimulation device to see if it helps symptoms and is safe over one year.

  Recruiting at 12 sites Stimuli Technology · Bron and 16 other locations · NCT07205445

• Sexual problems in women with relapsing-remitting multiple sclerosis

  See if sexual dysfunction is common in women aged 25-50 with relapsing-remitting MS and whether it's linked to fatigue, mood, bladder symptoms, and cognitive problems.

  Recruiting Ege University · Izmir, Bornova · NCT07193823

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.